Disclosures for "Cannabis Use Disorder in Multiple Sclerosis: Characterization of a National Sample of Patients Seeking Treatment"
-
Ms. Pehel has nothing to disclose.
-
Mr. Ko has nothing to disclose.
-
Mr. Fernandez has nothing to disclose.
-
Ms. Kreisberg has nothing to disclose.
-
Matthew Lustberg has nothing to disclose.
-
Dr. Pilloni has nothing to disclose.
-
Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.